Delivery Order SPE2DB22D1103-SPE2DB23FE4ZG
Award Date 7/20/23
Potential Completion Date 7/21/23
Potential Value $6.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $43,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561545342 DUPIXENT 300 MG/2 ML PEN 2ML. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all items to be delivered between July 19-20, 2023. No subcontractors or set...
- The Defense Logistics Agency awarded a $8,481 delivery order to Amerisourcebergen Drug Corporation for 4561355962 DUPIXENT 300 MG/2 ML PEN 2ML. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Performance will take place in Conshohocken, Pennsylvania over one day in late June 2023. No set aside designation or subcontractors were indicated. This order supports DLA's...
- The Defense Logistics Agency awarded a $9,725 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562194673 DUPIXENT 300 MG/2 ML PEN 2ML. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by September 18, 2023 to support DLA's mission of providing medical supplies and equipment to...
- The Defense Logistics Agency awarded a $9,291.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4562330261 DUPIXENT 300 MG/2 ML PEN 2ML. The order is being fulfilled under an existing Prime Vendor contract vehicle and will provide the specified pharmaceutical product to support DLA programs. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a one day period from September 27 through September 28,...
- The Defense Logistics Agency awarded a $5,872.25 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561889279 DUPIXENT 300 MG/2 ML PEN 2ML. The order was placed under an existing prime vendor contract vehicle and calls for the delivery of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania by August 22, 2023. Amerisourcebergen will serve as the prime contractor, with no mention of major subcontractors. As a leading provider of...
- The Defense Logistics Agency awarded a $17,411 delivery order to Amerisourcebergen Drug Corporation for 4561309773 DUPIXENT 300 MG/2 ML PEN 2ML. The firm fixed price order is being carried out under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over one day in June 2023. No set aside designation or subcontractors were indicated. This order supports DLA's...
- The Defense Logistics Agency awarded a $9,769 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561636259 DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a period of performance from July 28, 2023 through July 31, 2023. DLA will utilize this contract to procure specified pharmaceutical products from Amerisourcebergen, to support the Department of Defense's medical readiness and healthcare programs. The place of performance is Amerisourcebergen's facility located in...
- The Defense Logistics Agency awarded a $8,448.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a period of four days from July 21 through July 24, 2023. No set aside designation or subcontractors were identified. This...
- The Defense Logistics Agency awarded a $17,579 delivery order to Amerisourcebergen Drug Corporation for 4561327588 DUPIXENT 300 MG/2 ML PEN 2ML. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania, with performance spanning June 23 through June 26, 2023. DLA will utilize the pharmaceutical products under the order to support its medical supply chain initiatives. As the prime contractor, Amerisourcebergen will leverage its established...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,609.44 to Amerisourcebergen Drug Corporation for the purchase of 4562002758 DUPIXENT 300 MG/2 ML PEN 2ML. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements. The order is funded by the Defense Logistics Agency and supports the agency's medical supply chain and...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB23FE4ZGDelivery Order
The Defense Logistics Agency awarded a $6,609 delivery order to Amerisourcebergen Drug Corporation for 4561557399 DUPIXENT 300 MG/2 ML PEN 2ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from July 20th to July 21st, 2023. No set aside designation or subcontractors were identified. This order supports DLA's mission to provide medical supplies and equipment to military treatment facilities worldwide.
Generated 12/24/23, 1:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 7/20/23 |